Figure 1.
Raw, unadjusted means ±1 SE at baseline and 3-month and 6-month follow-up visits for aliskiren (circles) and placebo (squares) for peak exercise VO2 by expired gas analysis. The number of evaluable patients is shown for the specific outcome at each visit (aliskiren versus placebo).